Y070-0859 Screening compound: N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetamide

Y070-0859 Screening compound: N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetamide
Y070-0859 Screening compound: N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y070-0859
N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y070-0859

Molecular Formula

C27H25N3O5 (C27 H25 N3 O5)

Compound Name

N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl}acetamide

IUPAC name

N-(4-methoxyphenyl)-2-{1-[(2E)-3-(4-methoxyphenyl)prop-2-enoyl]-3-oxo-1234-tetrahydroquinoxalin-2-yl}acetamide

SMILES

COc1ccc(/C=C/C(N(C2CC(Nc(cc3)ccc3OC)=O)c(cccc3)c3NC2=O)=O)cc1

InChI

InChI=1S/C27H25N3O5/c1-34-20-12-7-18(8-13-20)9-16-26(32)30-23-6-4-3-5-22(23)29-27(33)24(30)17-25(31)28-19-10-14-21(35-2)15-11-19/h3-16,24H,17H2,1-2H3,(H,28,31)(H,29,33)/t24-/m0/s1

InChI Key

VQCJCQRPZIUZIU-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD03212310

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.51

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.633

Distribution Coefficient, logD

3.631

Water Solubility, LogSw

-4.08

Polar Surface Area

77.070

Acid Dissociation Constant (pKa)

9.73

Base Dissociation Constant (pKb)

3.65

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

14.80

Y070-0859 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Structure:
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with Y070-0859 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y070-0859?
Check Price and Availability of Y070-0859, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y070-0859 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y070-0859
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y070-0859
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y070-0859 available by request